跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COTELLIC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COTELLIC
Authorized
STANDARD
COTELLIC
Hoffmann-La Roche Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
26bfdd1880cdc731
Company
Hoffmann-La Roche Limited
Type
Standard
Approval Details
Approval Id
26bfdd1880cdc731
Drug Approval Canada Name
COTELLIC
Product Name
COTELLIC
Status
Marketed
Status Date
2016-04-06
Original Market Date
2016-04-06
Din
02452340
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EE02 COBIMETINIB
Atc Name
l 01 ee 02
Aig Number
0157890001
Company Name
Hoffmann-La Roche Limited
Company Address
7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8
Active Ingredients
COBIMETINIB (COBIMETINIB FUMARATE)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
26bfdd1880cdc731
Type
Standard
Back to Health Canada Approvals